Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study

Cancer Treat Rep. 1987 Dec;71(12):1309-10.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adult
  • Aged
  • Aziridines / therapeutic use*
  • Azirines / therapeutic use*
  • Benzoquinones*
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / drug therapy*

Substances

  • Aziridines
  • Azirines
  • Benzoquinones
  • diaziquone